Formulation optimization and in-vitro evaluation of propranolol hydrochloride extended release matrix formulation using factorial design
- At: 2011 FIP Congress in Hyderabad (India)
- Type: Poster
- By: SANTOSH KUMAR, Narla (Jawaharlal Technology University, Bangalore, India)
- Co-author(s): Nageswara Reddy, MVV (Aurobindo Pharma Limited, Hyderabad, India)
Chandra Mohan, Eaga (Genovo development limited, Bangalore, India)
The purpose of this research to formulate and systemically evaluate in-vitro performance of Propranolol Hydrochloride Extended release matrix formulation. The Propranolol Hydrochloride Extended release matrix formulations were prepared by direct compression process using the combination of highest viscosity grades of pH independent hydrophilic.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.